サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1507999

創薬技術の世界市場の機会と2033年までの戦略

Drug Discovery Technologies Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 339 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
創薬技術の世界市場の機会と2033年までの戦略
出版日: 2024年07月04日
発行: The Business Research Company
ページ情報: 英文 339 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の創薬技術市場は2018年に414億4,530万米ドルと評価され、CAGR9.0％以上で2023年まで成長しました。

医薬品研究開発（R&D）支出の増加

新薬の研究開発に対する製薬企業の支出の増加は、歴史的な期間における創薬技術市場の成長を牽引しました。製薬企業は、技術革新と医療格差への対応のために研究開発（R&D）に多額の投資を行いました。この投資が先進的な創薬技術の採用を促進し、開発プロセスを合理化しました。例えば、世界の製薬企業は2022年に研究開発に総額1,390億米ドルを費やしました。また2019年には、世界の製薬企業は売上高の平均約25％を研究開発に費やしています。したがって、製薬における研究開発費の増加は、創薬技術市場の成長を支えました。

目次

第1章 エグゼクティブサマリー

  • 創薬技術-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 創薬技術市場定義とセグメンテーション
  • 市場セグメンテーション：技術別
    • ハイスループットスクリーニング
    • ゲノミクス
    • バイオインフォマティクス
    • 組み合わせ化学
    • バイオチップ
    • バイオ分析機器
    • その他のテクノロジー
  • 市場セグメンテーション：薬の種類別
    • 低分子医薬品
    • 生物学的製剤
  • 市場セグメンテーション：疾患用途別
    • がん疾患
    • 免疫疾患
    • 神経疾患
    • 心血管疾患
    • その他の疾患用途別
  • 市場セグメンテーション：エンドユーザー別
    • 製薬会社
    • バイオ医薬品企業
    • バイオテクノロジー企業
    • 調査機関
    • その他のエンドユーザー

第7章 主要な市場動向

  • 医薬品開発を加速させる先進技術に注目
  • AI主導の創薬活動を拡大するためのインテリジェントロボットラボのイントロダクション
  • 創薬モデルの開発に重点を置いた投資
  • 主要企業間の戦略的パートナーシップとコラボレーション

第8章 創薬技術市場：マクロ経済シナリオ

  • COVID-19の影響：創薬技術市場
  • ウクライナ戦争の影響：創薬技術市場
  • 高インフレの影響：創薬技術市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績, 2018-2023
    • 市場促進要因, 2018-2023
    • 市場抑制要因, 2018-2023
  • 市場成長予測, 2023-2028, 2033年
    • 市場促進要因, 2023-2028
    • 市場抑制要因, 2023-2028

第10章 世界の創薬技術市場：セグメンテーション

  • 世界の創薬技術市場：技術別、実績と予測, 2018-2023, 2028年, 2033年
  • 世界の創薬技術市場：薬の種類別、実績と予測, 2018-2023, 2028年, 2033年
  • 世界の創薬技術市場：エンドユーザー別、実績と予測, 2018-2023, 2028年, 2033年
  • 世界の創薬技術市場：疾患用途別、実績と予測, 2018-2023, 2028年, 2033年

第11章 創薬技術市場：地域・国別分析

  • 世界の創薬技術市場：地域別、実績と予測, 2018-2023, 2028年, 2033年
  • 世界の創薬技術市場：国別、実績と予測, 2018-2023, 2028年, 2033年

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • AstraZeneca plc
  • Merck KGaA
  • GlaxoSmithKline plc
  • Pfizer Inc
  • Thermo Fisher Scientific Inc

第20章 その他の大手企業と革新的企業

  • Waters Corporation
  • Bio-Rad Laboratories
  • GE Healthcare Ltd.
  • Novartis AG
  • Bruker Corporation
  • Curia Global Inc.
  • AbbVie Inc.
  • Bayer AG
  • Agilent Technologies, Inc.
  • Sanofi S.A
  • Beckman Coulter Inc.
  • Evotec AG
  • Luminex Corporation
  • Standard BioTools Inc.
  • Caliper Life Sciences Inc.

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

  • Ampersand Biomedicines Acquired AbCheck
  • Sygnature Discovery Acquired SB Drug Discovery
  • Charles River Laboratories International Acquired SAMDI Tech
  • Verseon Acquired Edammo
  • Bayer Acquired Vividion Therapeutics

第24章 機会と戦略

  • 世界の創薬技術市場2028：新たな機会を提供する国
  • 世界の創薬技術市場2028：新たな機会を提供するセグメント
  • 世界の創薬技術市場2028：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第25章 創薬技術市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

目次
Product Code: o&s1258

Drug discovery technologies encompass a range of tools, methodologies and processes employed in the identification and development of new pharmaceutical compounds. This market is integral to the pharmaceutical and biotechnology industries, providing essential support for the discovery of both small molecule drugs and biologic drugs.

The drug discovery technologies market consists of revenues earned by entities (organizations, sole traders and partnerships) from sales of drug discovery technologies that include a range of scientific approaches and methodologies aimed at identifying and developing new pharmaceuticals for treating diseases.

The global drug discovery technologies market was valued at $41,445.3 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 9.0%.

Increased Pharmaceutical Research And Development (R&D) Expenditure

The increased pharmaceutical spending on research and development of new drugs drove the growth of the drug discovery technologies market during the historic period. Pharmaceutical firms invested significantly in research and development (R&D) to innovate and address medical gaps. This investment drove adoption of advanced drug discovery tech, streamlining development processes. For example, the global pharmaceutical companies collectively spent $139 billion on research and development in 2022. Also in 2019, globally pharmaceutical companies spent an average of roughly 25% of their revenue on R&D. Therefore, the increased research and development expenditure in pharmaceutical supported the growth of the drug discovery technologies market.

Introduction Of Intelligent Robotics Labs To Expand AI-Driven Drug Discovery Efforts

The introduction of intelligent robotics labs marks a significant advancement in AI (artificial intelligence)-driven drug discovery efforts. These labs are equipped with automated high-throughput screening, which allows for the rapid testing of millions of compounds against specific drug targets. For example, in January 2023, Insilico Medicine, a Hong Kong-based biotechnology company that provides drug discovery technologies, launched its 6th generation Intelligent Robotics Lab in Suzhou, China, to expedite its AI-driven drug discovery process. The lab employs advanced robotics and automation to streamline drug discovery stages, spanning from target identification to lead optimization. It features automated, high-throughput screening for rapid compound testing against drug targets and robotic systems for compound synthesis and purification, facilitating the creation of novel drug candidates.

The global drug discovery technologies market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up to 26.61% of the total market in 2022.

Drug Discovery Technologies Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global drug discovery technologies market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for drug discovery technologies? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The drug discovery technologies market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider drug discovery technologies market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by drug type, by disease application and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the drug discovery technologies market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by technology, by drug type, by disease application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for drug discovery technologies providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Technology: High Throughput Screening; Genomics; Bioinformatics; Combinational Chemistry; Biochips; Bioanalytical Instruments; Other Technologies
  • 2) By Drug Type: Small Molecule Drugs; Biologic Drugs
  • 3) By End-User: Pharmaceutical Companies; Biopharmaceutical Companies; Biotechnology Companies; Research Institutes; Other End-Users
  • 4) By Disease Application: Cancer Diseases; Immunological Diseases; Neurological Diseases; Cardiovascular Diseases; Other Disease Applications
  • Companies Mentioned: AstraZeneca plc.; Merck KGaA; GlaxoSmithKline Plc; Pfizer Inc.; Thermo Fisher Scientific
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; drug discovery technologies indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Drug Discovery Technologies - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Drug Discovery Technologies Market Definition And Segmentations
  • 6.4 Market Segmentation By Technology
    • 6.4.1 High Throughput Screening
    • 6.4.2 Genomics
    • 6.4.3 Bioinformatics
    • 6.4.4 Combinational Chemistry
    • 6.4.5 Biochips
    • 6.4.6 Bioanalytical Instruments
    • 6.4.7 Other Technologies
  • 6.5 Market Segmentation By Drug Type
    • 6.5.1 Small Molecule Drugs
    • 6.5.2 Biologic Drugs
  • 6.6 Market Segmentation By Disease Application
    • 6.6.1 Cancer Diseases
    • 6.6.2 Immunological Diseases
    • 6.6.3 Neurological Diseases
    • 6.6.4 Cardiovascular Diseases
    • 6.6.5 Other Disease Applications
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Pharmaceutical Companies
    • 6.7.2 Biopharmaceutical Companies
    • 6.7.3 Biotechnology Companies
    • 6.7.4 Research Institutes
    • 6.7.5 Other End-Users

7 Major Market Trends

  • 7.1 Focus On Advanced Technologies To Accelerate Drug Development
  • 7.2 Introduction Of Intelligent Robotics Labs To Expand AI-Driven Drug Discovery Efforts
  • 7.3 Investments Focused On Development Of Drug Discovery Models
  • 7.4 Strategic Partnerships And Collaborations Among Major Players

8 Drug Discovery Technologies Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Drug Discovery Technologies Market
  • 8.2 Impact Of The War In Ukraine On The Drug Discovery Technologies Market
  • 8.3 Impact Of High Inflation On The Drug Discovery Technologies Market

9 Global Market Size And Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Drug Discovery Technologies Market Segmentation

  • 10.1 Global Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Drug Discovery Technologies Market, Segmentation By Disease Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Drug Discovery Technologies Market, Regional and Country Analysis

  • 11.1 Global Drug Discovery Technologies Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Drug Discovery Technologies Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Asia-Pacific Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Drug Discovery Technologies Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
  • 12.9 Market Overview
    • 12.9.1 Country Information
    • 12.9.2 Market Information
    • 12.9.3 Background Information
    • 12.9.4 Government Initiatives
    • 12.9.5 Regulations
    • 12.9.6 Regulatory Bodies
    • 12.9.7 Major Associations
    • 12.9.8 Taxes Levied
    • 12.9.9 Corporate Tax Structure
    • 12.9.10 Investments
    • 12.9.11 Major Companies
  • 12.10 China Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Western Europe Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Drug Discovery Technologies Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Market
  • 13.12 Germany Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Market
  • 13.16 France Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 France Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Market
  • 13.20 Italy Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Market
  • 13.24 Spain Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Spain Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 Eastern Europe Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Drug Discovery Technologies Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 North America Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Drug Discovery Technologies Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
  • 15.9 Market Overview
    • 15.9.1 Country Information
    • 15.9.2 Market Information
    • 15.9.3 Background Information
    • 15.9.4 Government Initiatives
    • 15.9.5 Regulations
    • 15.9.6 Regulatory Bodies
    • 15.9.7 Major Associations
    • 15.9.8 Taxes Levied
    • 15.9.9 Corporate Tax Structure
    • 15.9.10 Investments
    • 15.9.11 Major Companies
  • 15.10 USA Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 South Korea Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South Korea Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South Korea Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Drug Discovery Technologies Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.10 Brazil Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Middle East Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Investments
    • 18.2.11 Major Companies
  • 18.3 Africa Drug Discovery Technologies Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Drug Discovery Technologies Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Drug Discovery Technologies Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • Company Profiles 288
  • 19.1 AstraZeneca plc
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
    • 19.1.3 Business Strategy
    • 19.1.4 Financial Overview
  • 19.2 Merck KGaA
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 GlaxoSmithKline plc
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Pfizer Inc
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Thermo Fisher Scientific Inc
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview

20 Other Major And Innovative Companies

  • 20.1 Waters Corporation
    • 20.1.1 Company Overview
    • 20.1.2 Products And Services
  • 20.2 Bio-Rad Laboratories
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
  • 20.3 GE Healthcare Ltd.
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
  • 20.4 Novartis AG
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
  • 20.5 Bruker Corporation
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
  • 20.6 Curia Global Inc.
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
  • 20.7 AbbVie Inc.
    • 20.7.1 Company Overview
    • 20.7.2 Products And Services
  • 20.8 Bayer AG
    • 20.8.1 Company Overview
    • 20.8.2 Products And Services
  • 20.9 Agilent Technologies, Inc.
    • 20.9.1 Company Overview
    • 20.9.2 Products And Services
  • 20.10 Sanofi S.A
    • 20.10.1 Company Overview
    • 20.10.2 Products And Services
  • 20.11 Beckman Coulter Inc.
    • 20.11.1 Company Overview
    • 20.11.2 Products And Services
  • 20.12 Evotec AG
    • 20.12.1 Company Overview
    • 20.12.2 Products And Services
  • 20.13 Luminex Corporation
    • 20.13.1 Company Overview
    • 20.13.2 Products And Services
  • 20.14 Standard BioTools Inc.
    • 20.14.1 Company Overview
    • 20.14.2 Products And Services
  • 20.15 Caliper Life Sciences Inc.
    • 20.15.1 Company Overview
    • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Ampersand Biomedicines Acquired AbCheck
  • 23.2 Sygnature Discovery Acquired SB Drug Discovery
  • 23.3 Charles River Laboratories International Acquired SAMDI Tech
  • 23.4 Verseon Acquired Edammo
  • 23.5 Bayer Acquired Vividion Therapeutics

24 Opportunities And Strategies

  • 24.1 Global Drug Discovery Technologies Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global Drug Discovery Technologies Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global Drug Discovery Technologies Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Drug Discovery Technologies Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer